{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:54:26Z","timestamp":1776254066168,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T00:00:00Z","timestamp":1728777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T00:00:00Z","timestamp":1728777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-04057-y","type":"journal-article","created":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T23:02:37Z","timestamp":1728860557000},"page":"420-429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hypoparathyroidism: an update on new therapeutic approaches"],"prefix":"10.1007","volume":"87","author":[{"given":"Marco","family":"Pitea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5378-1895","authenticated-orcid":false,"given":"Ruggero","family":"Lanzafame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0294-8591","authenticated-orcid":false,"given":"Elisa","family":"Sala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovica","family":"Croc\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4781-6715","authenticated-orcid":false,"given":"Stefano","family":"Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,13]]},"reference":[{"key":"4057_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/jc.2015-3908","volume":"101","author":"BL Clarke","year":"2016","unstructured":"B.L. Clarke, E.M. Brown, M.T. Collins, H. J\u00fcppner, P. Lakatos, M.A. Levine, M.M. Mannstadt, J.P. Bilezikian, A.F. Romanischen, R.V. Thakker, Epidemiology and diagnosis of hypoparathyroidism. J. Clin. Endocrinol. Metab. 101, 2284\u20132299 (2016). https:\/\/doi.org\/10.1210\/jc.2015-3908","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4057_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12020-019-02128-z","volume":"67","author":"G Tuli","year":"2020","unstructured":"G. Tuli, R. Buganza, D. Tessaris, S. Einaudi, P. Matarazzo, L. de Sanctis, Teriparatide (rhPTH 1\u201334) treatment in the pediatric age: long-term efficacy and safety data in a cohort with genetic hypoparathyroidism. Endocrine 67, 457\u2013465 (2020). https:\/\/doi.org\/10.1007\/s12020-019-02128-z","journal-title":"Endocrine"},{"key":"4057_CR3","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1210\/clinem\/dgaa113","volume":"105","author":"JP Bilezikian","year":"2020","unstructured":"J.P. Bilezikian, Hypoparathyroidism. J. Clin. Endocrinol. Metab. 105, 1722\u20131736 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa113","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4057_CR4","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1002\/jbmr.4667","volume":"37","author":"M Mannstadt","year":"2022","unstructured":"M. Mannstadt, L. Cianferotti, R.I. Gafni, F. Giusti, E.H. Kemp, C.A. Koch, K.L. Roszko, L. Yao, G.H. Guyatt, R.V. Yhakker, W. Xia, M.L. Brandi, Hypoparathyroidism: genetics and diagnosis. J. Bone Min. Res. 37, 2615\u20132629 (2022). https:\/\/doi.org\/10.1002\/jbmr.4667","journal-title":"J. Bone Min. Res."},{"key":"4057_CR5","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMcp1800213","volume":"380","author":"RI Gafni","year":"2019","unstructured":"R.I. Gafni, M.T. Collins, Hypoparathyroidism. N. Engl. J. Med. 380, 1738\u20131747 (2019). https:\/\/doi.org\/10.1056\/NEJMcp1800213","journal-title":"N. Engl. J. Med."},{"key":"4057_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1172\/JCI100224","volume":"7","author":"F Albright","year":"1929","unstructured":"F. Albright, R. Ellsworth, Studies on the physiology of the parathyroid glands: I. Calcium and phosphorus studies on a case of idiopathic hypoparathyroidism. J. Clin. Invest. 7, 183\u2013201 (1929)","journal-title":"J. Clin. Invest."},{"key":"4057_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","volume":"276","author":"KK Winer","year":"1996","unstructured":"K.K. Winer, J.A. Yanovski, G.B. Cutler Jr., Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hyoparathyroidism. JAMA 276, 631\u2013636 (1996)","journal-title":"JAMA"},{"key":"4057_CR8","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s40618-022-01800-y","volume":"45","author":"G Marcucci","year":"2022","unstructured":"G. Marcucci, G. Beccuti, I.G. Caros, F. Cetani, L. Cianferotti, A.M. Colao, C. Di Somma, M. Duradoni, A. Elefante, L. Ghizzoni, M. Giusti, A.G. Lania, E. Lavezzi, B. Madeo, G. Mantovani, C. Marcocci, L. Masi, S. Parri, F. Pigliaru, A. Santonati, A. Spada, L. Vera, M.L. Brandi, Multicenter retro\u2010prospective observational study on chronic hypoparathyroidism and rhPTH (1\u201384) treatment. J. Endocrinol. Invest. 45, 1653\u20131662 (2022). https:\/\/doi.org\/10.1007\/s40618-022-01800-y","journal-title":"J. Endocrinol. Invest."},{"key":"4057_CR9","doi-asserted-by":"publisher","first-page":"115834","DOI":"10.1016\/j.bone.2020.115834","volume":"144","author":"E Laurer","year":"2021","unstructured":"E. Laurer, J. Gr\u00fcnberger, U. Naidoo, R. Lanzersdorfer, M. Wilmleitner, K. Tischlinger, W. H\u00f6gler, Recombinant human parathyroid hormone (1-84) replacement therapy in a child with hypoparathyroidism. Bone 144, 115834 (2021). https:\/\/doi.org\/10.1016\/j.bone.2020.115834","journal-title":"Bone"},{"key":"4057_CR10","unstructured":"https:\/\/www.aifa.gov.it\/en\/-\/nota-informativa-importante-su-natpar-ormone-paratiroideo-1"},{"key":"4057_CR11","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.ecl.2018.07.013","volume":"47","author":"G Tabacco","year":"2018","unstructured":"G. Tabacco, J.P. Bilezikian, New directions in treatment of hypoparathyroidism. Endocrinol. Metab. Clin. North Am. 47, 901\u2013915 (2018). https:\/\/doi.org\/10.1016\/j.ecl.2018.07.013","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"4057_CR12","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1210\/jc.2011-1359","volume":"96","author":"A Linglart","year":"2011","unstructured":"A. Linglart, A. Rothenbuhler, I. Gueorgieva, P. Lucchini, C. Silve, P. Bougn\u00e8res, Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism. J. Clin. Endocrinol. Metab. 96, 3308\u20133312 (2011). https:\/\/doi.org\/10.1210\/jc.2011-1359","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4057_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1210\/jc.2011-1908","volume":"97","author":"KK Winer","year":"2012","unstructured":"K.K. Winer, B. Zhang, J.A. Shrader, D. Peterson, M. Smith, P.S. Albert, G.B. Cutler Jr., Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. J. Clin. Endocrinol. Metab 97, 391\u2013399 (2012). https:\/\/doi.org\/10.1210\/jc.2011-1908","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"4057_CR14","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1210\/jc.2009-2464","volume":"95","author":"KK Winer","year":"2010","unstructured":"K.K. Winer, N. Sinaii, J. Reynolds, D. Peterson, K. Dowdy, G.B. Cutler Jr., Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. J. Clin. Endocrinol. Metab. 95, 2680\u20132688 (2010). https:\/\/doi.org\/10.1210\/jc.2009-2464","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4057_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/01926230252929882","volume":"30","author":"JL Vahle","year":"2002","unstructured":"J.L. Vahle, M. Sato, G.G. Long, J.K. Young, P.C. Francis, J.A. Engelhardt, M.S. Westmore, Y. Linda, J.B. Nold, Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicol. Pathol. 30, 312\u2013321 (2002). https:\/\/doi.org\/10.1080\/01926230252929882","journal-title":"Toxicol. Pathol."},{"key":"4057_CR16","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1210\/clinem\/dgab577","volume":"107","author":"A Khan","year":"2022","unstructured":"A. Khan, L. Rejnmark, M. Rubin, P. Schwarz, T. Vokes, B. Clarke, I. Ahmed, L. Hofbauer, C. Marcocci, U. Pagotto, A. Palermo, E. Eriksen, M. Brod, D. Markova, A. Smith, S. Pihl, S. Mourya, D.B. Karpf, A.D. Shu, PaTH forward: a randomized, double-blind, placebo-controlled phase 2 trial of TransCon PTH in adult hypoparathyroidism. J. Clin. Endocrinol. Metab. 107, e372\u2013e385 (2022). https:\/\/doi.org\/10.1210\/clinem\/dgab577","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4057_CR17","unstructured":"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/yorvipath#:~:text=Other%20information%20about%20Yorvipath,EU%20on%2017%20November%202023"},{"key":"4057_CR18","unstructured":"https:\/\/investors.ascendispharma.com\/news-releases\/news-release-details\/ascendis-pharma-announces-extension-us-food-and-drug-1"},{"key":"4057_CR19","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1002\/jbmr.3824","volume":"34","author":"L Holten-Andersen","year":"2019","unstructured":"L. Holten-Andersen, S. Pihl, C.E. Rasmussen, J. Zettler, G. Maitro, J. Baron, S. Heinig, E. Hoffmann, T. Wegge, M. Krusch, F. Faltinger, S. Kilian, K. Sprogoe, D.B. Karpf, V.M. Breinholt, F. Cleemann, Design and preclinical development of TransCon PTH, an investigational sustained-release PTH replacement therapy for hypoparathyroidism. J. Bone Miner. Res. 34, 2075\u20132086 (2019). https:\/\/doi.org\/10.1002\/jbmr.3824","journal-title":"J. Bone Miner. Res."},{"issue":"Supplement 1","key":"4057_CR20","doi-asserted-by":"publisher","first-page":"A193","DOI":"10.1210\/jendso\/bvac150.398","volume":"6","author":"I Ahmed","year":"2022","unstructured":"I. Ahmed, E. Eriksen, R.L. Hofbaue, A. Khan, J. Le, C. Marcocci, D. Markova, U. Pagotto, A. Palermo, S. Pihl, L. Rjnmark, P. Schwarz, A. Shu, C. Sibley, S. Vansaghi, T. Vokes, B. Clarke, OR21-1 The PaTH forward trial: efficacy and safety of TransCon PTH through week 84 for adults with hypoparathyroidism. J. Endocr. Soc. 6(Supplement 1), A193 (2022). https:\/\/doi.org\/10.1210\/jendso\/bvac150.398","journal-title":"J. Endocr. Soc."},{"key":"4057_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jbmr.4726","volume":"38","author":"AA Khan","year":"2023","unstructured":"A.A. Khan, M.R. Rubin, P. Schwarz, T. Vokes, D.M. Shoback, C. Gagnon, A. Palermo, C. Marcocci, B.L. Clarke, L.G. Abbott, L.C. Hofbauer, L. Kohlmeier, S. Pihl, X. An, W.F. Eng, A.R. Smith, J. Ukena, C.T. Sibley, A.D. Shu, L. Rejnmark, Efficacy and safety of parathyroid hormone replacement with TransCon PTH in hypoparathyroidism: 26-week results from the Phase 3 PaTHway Trial. J. Bone Miner. Res. 38, 14\u201325 (2023). https:\/\/doi.org\/10.1002\/jbmr.4726","journal-title":"J. Bone Miner. Res."},{"key":"4057_CR22","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1007\/s12325-024-02843-8","volume":"41","author":"L Rejnmark","year":"2024","unstructured":"L. Rejnmark, E.O. Gosmanova, A.A. Khan, N. Makita, Y. Imanishi, Y. Takeuchi, S. Sprague, D.M. Shoback, L. Kohlmeier, M.R. Rubin, A. Palermo, P. Schwarz, C. Gagnon, E. Tsourdi, C. Zhao, M.A. Makara, M.S. Ominsky, B. Lai, J. Ukena, C.T. Sibley, A.D. Shu, Palopegteriparatide treatment improves renal function in adults with chronic hypoparathyroidism: 1-year results from the phase 3 PaTHway Trial. Adv Ther 41, 2500\u20132518 (2024). https:\/\/doi.org\/10.1007\/s12325-024-02843-8","journal-title":"Adv Ther"},{"key":"4057_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jbmr.2917","volume":"32","author":"J Guo","year":"2017","unstructured":"J. Guo, A. Khatri, A. Maeda, J.T. Potts Jr, H. J\u00fcppner, T.J. Gardella, Prolonged pharmacokinetic and pharmacodynamic actions of a pegylated parathyroid hormone (1-34) peptide fragment. J. Bone Miner. Res. 32, 86\u201398 (2017). https:\/\/doi.org\/10.1002\/jbmr.2917","journal-title":"J. Bone Miner. Res."},{"issue":"Supplement 1","key":"4057_CR24","doi-asserted-by":"publisher","first-page":"A254","DOI":"10.1210\/jendso\/bvab048.516","volume":"5","author":"S Allas","year":"2021","unstructured":"S. Allas, M. Ovize, M.D. Culler, C. Geraul, J. van de Wetering, M. Mannstadt, A single administration of AZP-3601, a Novel, Long-Acting PTH analog, induces a significant and sustained calcemic response: preliminary data from a randomized, double-blind, placebo-controlled phase 1 study. J. Endocr. Soc. 5(Supplement 1), A254 (2021). https:\/\/doi.org\/10.1210\/jendso\/bvab048.516","journal-title":"J. Endocr. Soc."},{"key":"4057_CR25","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/jbmr.2811","volume":"31","author":"M Shimizu","year":"2016","unstructured":"M. Shimizu, E. Joyashiki, H. Noda, T. Watanabe, M. Okazaki, M. Nagayasu, K. Adachi, T. Tamura, J.T. Potts Jr., T.J. Gardella, Y. Kawabe, Pharmacodynamic actions of a long-acting PTH analog (LA-PTH) in thyroparathyroidectomized (TPTX) rats and normal monkeys. J. Bone Miner. Res. 31, 1405\u20131412 (2016). https:\/\/doi.org\/10.1002\/jbmr.2811","journal-title":"J. Bone Miner. Res."},{"key":"4057_CR26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/jbmr.2769","volume":"31","author":"R Bi","year":"2016","unstructured":"R. Bi, Y. Fan, K. Lauter, J. Hu, T. Watanabe, J. Cradock, N.Q. Yua, T. Gardella, M. Mannstadt, Diphtheria toxin- and GFP-based mouse models of acquired hypoparathyroidism and treatment with a long-acting parathyroid hormone analog. J. Bone Miner. Res. 31, 975\u2013984 (2016). https:\/\/doi.org\/10.1002\/jbmr.2769","journal-title":"J. Bone Miner. Res."},{"issue":"Supplement 1","key":"4057_CR27","doi-asserted-by":"publisher","first-page":"A196","DOI":"10.1210\/jendso\/bvac150.403","volume":"6","author":"M Culler","year":"2022","unstructured":"M. Culler, T. Gardella, C. Aksu, AZP-3601, a Long-Acting Parathyroid Hormone (PTH) Analog, Normalizes Blood Calcium in Thyroparathyroidectomized (TPTX) rats without causing deleterious changes in bone. J. Endocr. Soc. 6(Supplement 1), A196 (2022). https:\/\/doi.org\/10.1210\/jendso\/bvac150.403","journal-title":"J. Endocr. Soc."},{"issue":"Suppl 1","key":"4057_CR28","doi-asserted-by":"publisher","first-page":"bvad114.562","DOI":"10.1210\/jendso\/bvad114.562","volume":"7","author":"P Kamenicky","year":"2023","unstructured":"P. Kamenicky, I. Takacs, E. Mezosi, A. Soto, L. Figueres, S. Lemoine, F. Borson-Chazot, I. Capel, M.A. Angeles Artazcoz Galvez Moreno, M. Ovize, T. OuldRouis, S. Allas, M. Sumeray, M. Mannstadt, OR23-04 treatment of chronic hypoparathyroidism with eneboparatide (AZP-3601), a novel PTH 1 receptor agonist: results from a phase 2 trial. J. Endocr. Soc. 7(Suppl 1), bvad114.562 (2023). https:\/\/doi.org\/10.1210\/jendso\/bvad114.562","journal-title":"J. Endocr. Soc."},{"key":"4057_CR29","unstructured":"https:\/\/amolytpharma.com\/2024\/05\/02\/amolyt-pharma-granted-fda-fast-track-designation-for-eneboparatide-for-the-treatment-of-hypoparathyroidism\/"},{"key":"4057_CR30","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1111\/bph.14086","volume":"175","author":"FM Hannan","year":"2018","unstructured":"F.M. Hannan, M.K. Olesen, R.V. Thakker, Calcimimetic and calcilytic therapies for inherited disorders of the calcium-sensing receptor signalling pathway. Br. J. Pharmacol. 175, 4083\u20134094 (2018). https:\/\/doi.org\/10.1111\/bph.14086","journal-title":"Br. J. Pharmacol."},{"key":"4057_CR31","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1002\/jbmr.4659","volume":"37","author":"KL Roszko","year":"2022","unstructured":"K.L. Roszko, L.M. Stapleton Smith, A.V. Sridhar, M.S. Roberts, I.R. Hartley, R.I. Gafni, M.T. Collins, J.C. Fox, E.F. Nemeth, Autosomal dominant hypocalcemia type 1: a systematic review. J. Bone. Miner. Res. 37, 1926\u20131935 (2022). https:\/\/doi.org\/10.1002\/jbmr.4659","journal-title":"J. Bone. Miner. Res."},{"key":"4057_CR32","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fphys.2016.00458","volume":"7","author":"KL Roszko","year":"2016","unstructured":"K.L. Roszko, R.D. Bi, M. Mannstadt, Autosomal dominant hypocalcemia (hypoparathyroidism) types 1 and 2. Front. Physiol. 7, 458 (2016). https:\/\/doi.org\/10.3389\/fphys.2016.00458","journal-title":"Front. Physiol."},{"key":"4057_CR33","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ajhg.2020.04.006","volume":"106","author":"R Dershem","year":"2020","unstructured":"R. Dershem, C.M. Gorvin, R.P.R. Metpally, S. Krishnamurthy, D.T. Smelser, F.M. Hannan, D.J. Carey, R.V. Thakker, G.E. Breitwieser; Regeneron Genetics Center., Familial hypocalciuric hypercalcemia type 1 and autosomal-dominant hypocalcemia type 1: prevalence in a large healthcare population. Am. J. Hum. Genet. 106, 734\u2013747 (2020). https:\/\/doi.org\/10.1016\/j.ajhg.2020.04.006","journal-title":"Am. J. Hum. Genet."},{"key":"4057_CR34","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1056\/NEJMc2302708","volume":"389","author":"RI Gafni","year":"2023","unstructured":"R.I. Gafni, I.R. Hartley, K.L. Roszko, E.F. Nemeth, K.A. Pozo, E. Lombardi, A.V. Sridhar, M.S. Roberts, J.C. Fox, M.T. Collins, Efficacy and safety of encaleret in autosomal dominant hypocalcemia type 1. N. Engl. J. Med. 389, 1245\u20131247 (2023). https:\/\/doi.org\/10.1056\/NEJMc2302708","journal-title":"N. Engl. J. Med."},{"key":"4057_CR35","doi-asserted-by":"publisher","first-page":"10272","DOI":"10.3390\/ijms221910272","volume":"22","author":"F Miglietta","year":"2021","unstructured":"F. Miglietta, G. Palmini, I.F. Giust, S. Donati, C. Aurilia, T. Iantomasi, M.L. Brandi, Hypoparathyroidism: state of the art on cell and tissue therapies. Int. J. Mol. Sc.i 22, 10272 (2021). https:\/\/doi.org\/10.3390\/ijms221910272","journal-title":"Int. J. Mol. Sc.i"},{"key":"4057_CR36","first-page":"34","volume":"78","author":"SA Wells","year":"1975","unstructured":"S.A. Wells, J.C. Gunnells, J.D. Shelburne, A.B. Schneider, L.M. Sherwood, Transplantation of the parathyroid glands in man: clinical indications and results. Surgery 78, 34\u201344 (1975)","journal-title":"Surgery"},{"key":"4057_CR37","first-page":"508","volume":"42","author":"FH Lahey","year":"1926","unstructured":"F.H. Lahey, The transplantation of parathyroids in partial thyroidectomy. Surg. Gynecol. Obstet 42, 508\u2013509 (1926)","journal-title":"Surg. Gynecol. Obstet"},{"key":"4057_CR38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0039-6060(99)70201-1","volume":"125","author":"T Kikumori","year":"1999","unstructured":"T. Kikumori, T. Imai, Y. Tanaka, M. Oiwa, T. Mase, H. Funahashi, Parathyroid autotransplantation with total thyroidectomy for thyroid carcinoma: long-term follow-up of grafted parathyroid function. Surgery 125, 504\u2013508 (1999)","journal-title":"Surgery"},{"key":"4057_CR39","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.21037\/gs.2017.09.15","volume":"6","author":"G Hicks","year":"2017","unstructured":"G. Hicks, R. George, M. Sywak, Short and long-term impact of parathyroid autotransplantation on parathyroid function after total thyroidectomy. Gland. Surg. 6, S75\u2013S85 (2017). https:\/\/doi.org\/10.21037\/gs.2017.09.15","journal-title":"Gland. Surg."},{"key":"4057_CR40","doi-asserted-by":"publisher","first-page":"e13231","DOI":"10.1097\/MD.0000000000013231","volume":"97","author":"A Su","year":"2018","unstructured":"A. Su, Y. Gong, T. Wei, R. Gong, Z. Li, J. Zhu, A new classification of parathyroid glands to evaluate in situ preservation or autotransplantation during thyroid surgery. Medicine 97, e13231 (2018). https:\/\/doi.org\/10.1097\/MD.0000000000013231","journal-title":"Medicine"},{"key":"4057_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/medsci10010019","volume":"10","author":"JLH Zhang","year":"2022","unstructured":"J.L.H. Zhang, N.M. Appleman-Dijkstra, A. Schepers, Parathyroid allotransplantation: a systematic review. Med. Sci. 10, 19 (2022). https:\/\/doi.org\/10.3390\/medsci10010019","journal-title":"Med. Sci."},{"key":"4057_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1006\/jsre.2000.6054","volume":"96","author":"L Picariello","year":"2001","unstructured":"L. Picariello, S. Benvenuti, R. Recenti, L. Formigli, A. Falchetti, A. Morelli, L. Masi, F. Tonelli, P. Cicchi, M.L. Brandi, Microencapsulation of human parathyroid cells: an \u201cin vitro\u201d study. J. Surg. Res. 96, 81\u201389 (2001). https:\/\/doi.org\/10.1006\/jsre.2000.6054","journal-title":"J. Surg. Res."},{"key":"4057_CR43","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1525-1594.2004.00051.x","volume":"28","author":"CH Lee","year":"2004","unstructured":"C.H. Lee, Y.J. Wang, S.M. Kuo, S.J. Chang, Microencapsulation of parathyroid tissue with photosensitive Poly(L-Lysine) and short chain alginate-Co-MPEG. Artif. Organs 28, 537\u2013542 (2004). https:\/\/doi.org\/10.1111\/j.1525-1594.2004.00051.x","journal-title":"Artif. Organs"},{"key":"4057_CR44","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/aor.13475","volume":"43","author":"E Yucesan","year":"2019","unstructured":"E. Yucesan, H. Basoglu, B. Goncu, F. Akbas, Y.E. Ersoy, E. Aysan, Microencapsulated parathyroid allotransplantation in the omental tissue. Artif. Organs. 43, 1022\u20131027 (2019). https:\/\/doi.org\/10.1111\/aor.13475","journal-title":"Artif. Organs."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04057-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-04057-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04057-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T12:30:22Z","timestamp":1739190622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-04057-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,13]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["4057"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-04057-y","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,13]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript is a review of the literature, and therefore no ethical approval was necessary.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}